Team

Leadership Team

 

Seulki Lee, PhD
CEO

Dr. Lee, founder, is an expert in drug and protein delivery. His research is focused on identifying novel targets critically involved in the origination of the disease. He invented NLY01 and, in collaboration with Dr. Ted Dawson’s team, at John’s Hopkins School of Medicine, proved its exceptional neuroprotective activity in animal models of Parkinson’s disease and Alzheimer’s disease, which led to founding of Neuraly. Dr. Lee was Associate Professor of Radiology and Radiological Science at Johns Hopkins School of Medicine.

Viktor Roschke, PhD
CSO and Head of R&D

Dr. Roschke, co-founder, is Chief Scientific Officer and Head of Research and Development. He has more than 20 years of experience in drug development as senior executive in pharmaceutical and biotech companies such as Human Genome Sciences, Cogenesys, and Teva Pharmaceuticals.

 

Scientific Advisors

 
Ted Dawson.png

Ted Dawson, MD, PhD
Scientific Co-Founder, Advisor

Warren.jpg

Warren Olanow, MD
Clinical Advisor

Ko.jpg

Han Seok Ko, PhD
Scientific Co-Founder, Advisor

Martin Pompoer.png

Martin Pomper, MD, PhD
Scientific Co-Founder, Advisor

Karl.jpg

Karl Kieburtz, MD, MPH
Clinical Advisor

Team

D&D Pharmatech - Mark Story Photos-2471.jpg

Adam Bell, PhD
VP, Translational Medicine and Regulatory Affairs

Ted Dawson.png

Barbara Rempe, SHRM-CP
Human Resource Manager

Seulki Lee.jpg

Celia Baula, PMP, MBA
Senior Director, Program Management and Quality Systems

Don Ho.jpg

Don Ho, PhD
Director, Intellectual Property

Yumin Oh.jpg

Yumin Oh, PhD
Principal Scientist, Drug Discovery

Svetlana Sosnovstseva.jpg

Subbu Karanth, PhD
Director, Toxicology

Svetlana Sosnovstseva.jpg

Svetlana Sosnovtseva, MS
Senior Director, Assay Development

D&D Pharmatech - Mark Story Photos-2654.jpg

Yen Lin, PhD
VP, Technology Development and Manufacturing

Anna Nesterenko, CPA
Director, Accounting and Finance

D&D Pharmatech - Mark Story Photos-2525.jpg

Donara Abramyan, PhD
Principal Scientist, Assay Development

D%2526D%2BPharmatech%2B-%2BMark%2BStory%2BPhotos-2479-2.jpg

Jacob Kim, MBA, CPA
Accounting and Finance

Benjamin Gibson, MSc
Alliance Management

Irina Grineva. MS
Assay Development